MENINGOKOKK INFEKSIYASINI BOLALARDA UCHRASH SABABLARINI ANIQLASH VA PROFILAKTIKA CHORALARINI TAKOMILLASHTIRISH
Abstract
Meningokokk infeksiyasi bolalarda og‘ir kechuvchi, tez rivojlanadigan va hayot uchun xavfli kasalliklardan biridir. Ushbu mavzuda meningokokk infeksiyasining klinik belgilari, erta aniqlash, zamonaviy davolash usullari va kasallikning oldini olish choralariga e’tibor qaratiladi. Shuningdek, meningokokk infeksiyasiga chalingan bolalarni parvarish qilishning asosiy tamoyillari, immunizatsiya va epidemiologik nazorat usullari bayon etiladi. Kasallikning erta tashxisi va samarali profilaktikasi bolalar o‘rtasida o‘lim va asoratlar ko‘rsatkichini sezilarli darajada kamaytiradi.
References
1. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa / O.B. Brynildsrud, V. Eldholm, J. Bohlin [et al.] // Proceedings of the National Academy of Sciences. - 2018. - Vol. 115, № 21. - P. 5510-5515.
2. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones / T.R. Shultz, J.W. Tapsall, P.A. White [et al.] // Antimicrobial Agents and Chemotherapy. - 2000. - Vol. 44, № 4. - P. 1116.
3. An overview of meningococcal disease in India: Knowledge gaps and potential solutions / T.J. John, S. Gupta, A.J. Chitkara [et al.] // Vaccine. - 2013. - Vol. 31, № 25. - P. 2731-2737.
4. Arreaza, L. Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers / L. Arreaza, L. De La Fuente, J. Vázquez // Antimicrobial Agents and Chemotherapy. - 2000. - Vol. 44, № 6. - P. 1705-1707.
5. Atkinson, B. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention / B. Atkinson, A. Gandhi, P. Balmer // Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. - 2016. - Vol. 36, № 8. - P. 880-892.
6. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci / C. Stinson, C. Burman, J. Presa [et al.] // Epidemiology and Infection. - 2020. - Vol. 148. - P. e12.
7. Australian Meningococcal Surveillance Programme Annual report of the Australian Meningococcal Surveillance Programme, 2009 // Communicable diseases intelligence. - 2010. - Vol. 34, № 3. - P. 291-302.
8. Bakir, M. Meningococcal serogroup B disease in Turkey: A guess or reality? / M. Bakir // Human Vaccines and Immunotherapeutics. - 2014. - Vol. 10, № 6. - P. 1721-1724.
9. Barnett, E.D. Role of Immigrants and Migrants in Emerging Infectious Diseases / E.D. Barnett, P.F. Walker // Medical Clinics of North America. - 2008. - Vol. 92, № 6. - P. 1447-1458.
10. Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis / B. Wang, R. Santoreneos, L. Giles [et al.] Vaccine. - 2019. - Vol. 37, № 21. - P. 2768-2782.
